|
Delayed
Nasdaq
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
-.--% | - |
| 21-01-19 | Integra LifeSciences Holdings Corporation completed the acquisition of ACell, Inc for approximately $410 million. | CI |
| 20-12-22 | ACell, Inc. Announces CE Mark Approval | CI |
| Manager | Title | Age | Since |
|---|---|---|---|
Matthew R. Kunst
DFI | Director of Finance/CFO | - | 2019-12-31 |
Patty Meehan
ADM | Chief Administrative Officer | - | 2001-12-31 |
Jim Kuras
CTO | Chief Tech/Sci/R&D Officer | - | 2019-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Kyle C. Kerbawy
CHM | Chairman | 79 | 2015-07-31 |
Sally L. Maher
BRD | Director/Board Member | - | 2019-04-30 |
| Director/Board Member | 71 | 2019-06-30 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 340M | |
| +1.16% | -1.13% | -17.92% | +8.27% | 179B | |
| +0.02% | +4.24% | -19.82% | +16.53% | 118B | |
| -1.22% | +0.70% | +1.27% | +31.80% | 117B | |
| +2.29% | +17.36% | -41.94% | +9.49% | 93.26B | |
| -2.21% | -2.91% | +0.74% | +75.30% | 63.16B | |
| -1.06% | +1.75% | +13.50% | +80.00% | 55.68B | |
| -0.75% | +3.73% | +6.64% | -22.28% | 54.18B | |
| -1.13% | +0.00% | -12.25% | +31.02% | 44.15B | |
| +0.17% | +5.85% | -4.92% | -10.64% | 33.95B | |
| Average | -0.27% | +3.24% | -8.30% | +24.39% | 75.88B | |
| Weighted average by Cap. | -0.00% | +3.09% | -11.69% | +22.47% |
| 2018 | 2019 | |
|---|---|---|
| Net sales | 89.22M 79.65M 73.53M 66.72M 125M 8.47B 127M 885M 350M 4.43B 335M 328M 13.99B | 101M 89.99M 83.06M 75.38M 141M 9.57B 143M 1B 396M 5.01B 378M 370M 15.81B |
| Net income | -3.13M -2.8M -2.58M -2.34M -4.39M -297M -4.45M -31.07M -12.29M -156M -11.75M -11.5M -491M | 1.45M 1.29M 1.19M 1.08M 2.03M 138M 2.06M 14.38M 5.69M 71.98M 5.44M 5.32M 227M |
| Net Debt | - | - |
Employees
-
- Stock Market
- Stocks
- ACLL Stock
Select your edition
All financial news and data tailored to specific country editions
